Novartis bought his first startup for $3.9 billion. Now this physicist is trying to sell Europe on a new generation of nuclear energy

By Peter VanhamEditorial Director, Leadership
Peter VanhamEditorial Director, Leadership

Peter Vanham is editorial director, leadership, at Fortune.

Nicholas GordonBy Nicholas GordonAsia Editor
Nicholas GordonAsia Editor

Nicholas Gordon is an Asia editor based in Hong Kong, where he helps to drive Fortune’s coverage of Asian business and economics news.

A man with gray hair wearing a blue suit and tie looks over his right shoulder
Newcleo CEO Stefano Buono is making inroads in Italy and France, where a Newcleo reactor will be operational by 2030.
Benjain Girette—Bloomberg/Getty Images

Good morning, and welcome to the very first edition of CEO Weekly Europe. 

Does Europe need Nuclear Now? Filmmaker Oliver Stone certainly thinks so. He’s going on a roadshow in Italy next week to present his latest documentary with the same title. 

Joining the American on stage is Stefano Buono, the founder of two nuclear startups and coproducer of the film. Buono is a man with a mission: to reconvert Europe to nuclear energy and increase nuclear’s share of the growing electricity market to over 30%. The Italian believes that betting big on a new type of nuclear is the only way for Europe’s economy to remain competitive globally. Is he right?

It was just a few years ago that Germany, Europe’s largest economy, firmly said no. For much of the past decade, the country went all-in on renewables and Russian gas. It closed its last remaining nuclear plants this year. But the timing of that nuclear phaseout, we know now, couldn’t have been worse. 

Last year, Russia’s invasion of Ukraine ended Germany’s fragile energy balance. Germany turned to Norwegian gas after rejecting Russian supplies. That abrupt shift came at a substantial cost. This year, Germany is the only major Western economy to experience a recession. And while the country is scaling up its solar and wind energy sources, daily fluctuations in supply mean the country’s—and the continent’s—energy woes are far from over.

According to Buono, a new generation of nuclear energy is the answer to that problem. “The energy cost is the fundamental asset that is moving the economy,” he told me in a phone interview from Turin. And since nuclear energy can “flatten the prices,” it will be indispensable going forward, he said. “Nuclear is necessary in the energy mix because it can supply best programmable energy,” he said. 

Even in a country like Germany, nuclear could supply up to 30% of energy, Buono said. The lead-cooled nuclear plants Buono advocates for are allegedly much more sustainable, too. The nuclear waste produced in them stops being radioactive in a few hundred years—as opposed to thousands of years for waste from conventional plants—and creates a lot less waste to begin with, Buono claims. And of course, they have zero CO2 emissions. 

Whether the founder will be able to convince Germans with those arguments remains to be seen. But in France and Italy, the EU’s next two biggest economies, his company Newcleo is making inroads. By 2030, the first Newcleo nuclear plant should be operational in France

That traction, together with the EU’s push to end oil and gas subsidies by 2030, may indeed herald a new era of nuclear in Europe. It may be a good thing, indeed. Europe’s companies desperately need affordable energy to remain competitive. And the continent needs an alternative to coal, oil, and gas to get to “net zero” in terms of CO2 emissions.  

For Buono, there may be another silver lining. After selling his nuclear medicine startup, Advanced Accelerator Applications, a few years ago, he hopes Newcleo will be his first startup to turn into a Fortune 500 Europe company. “It will be a high multibillion euro company in the next decade,” he predicted. Given that Novartis bought his first company for $3.9 billion in 2017, we wouldn’t bet against him. 

What do you think of the push for nuclear in Europe? We’d love to hear your thoughts.

More news below.

Peter Vanham
peter.vanham@fortune.com
@petervanham

TOP NEWS

EV plans

Nissan will invest an additional $2.5 billion to expand its production of EVs and EV batteries in Sunderland, U.K. The Japanese automaker has pledged to only sell EVs in Europe by 2030. Nissan is not the only automaker to expand its EV plans in the region. Last week, Stellantis, the owner of brands like Fiat and Jeep, announced it will partner with China’s CATL to build a new European battery plant. Financial Times

Credit Suisse’s downfall

Analysts trying to determine how Credit Suisse collapsed so quickly are blaming former chair Urs Rohner, who served between 2011 and 2021. Rohner did not control risks at the Swiss bank during his tenure and reportedly pushed back against compliance officers evaluating perks and other informal practices. Sergio Ermotti, CEO of UBS, which acquired Credit Suisse earlier this year, said in a speech last week that his erstwhile competitor had “repeated risk management and operational failures.” The Wall Street Journal

The NHS’s new deal

Palantir, the tech company founded by Peter Thiel, won a deal worth $413 million to overhaul the data of the National Health Service, the U.K.’s public health system. Palantir will help the NHS analyze data and spot trends, slashing wait times. Yet watchdogs are worried that the deal will give personal data to the already controversial company. Fortune

AROUND THE WATERCOOLER

CEO of Europe’s largest budget airline brushes off Italy’s investigation into low-cost carriers as a ‘joke’ by Ryan Hogg

Spotify’s U.K. boss took paid paternity leave 26 times longer than the average American dad—but it took a conversation with his manager to fully embrace it by Ryan Hogg

A Spanish agency became so sick of models and influencers that they created their own with AI—and she’s raking in up to $11,000 a month by Ryan Hogg

Chanel heir with a $48 billion fortune is the richest person in Switzerland thanks to a post-pandemic luxury goods boom by Chloe Taylor

New car sales in Europe pop as EVs record 36% increase and hybrids account for nearly 3 in 10 vehicles sold by Reuters

Novo Nordisk responds to U.S. rival Eli Lilly by announcing new $2.3 billion investment in France to keep up with soaring demand for weight-loss drugs by Reuters

This is the web version of Fortune CEO Weekly Europe, a newsletter on the companies and industry leaders shaping every facet of business in Europe. Sign up for free.